Health Care Activity – Page 6

AI Guidance for Investors: Navigating the Future with Strategic Approaches and Regulatory Insights

7 months ago talkbio0Tagged Adoption, Advice, Artificial Intelligence, Computer Security, governance, Health care facility, investors, Mapping Strategies, Regulatory Impact, Risk, Strategic AI

AI Guidance for Investors, Strategic AI Adoption, Regulatory Impact on AI, Cybersecurity Risks in AI, AI Mapping Strategies, Data Governance in AI, Future of AI in Healthcare

Navigating Complex Regulatory Landscapes: The Importance of External Support for Biotech Sponsors in IRB, IBC, DMCs, and EACs

7 months ago talkbio0Tagged 6-aminocaproic acid, Biotech sponsors, Clinical Trials, Clinical Trials Data Monitoring Committees, DMCs, Ethics Advisory Committees, Ethics Committees, Research, gene therapy, IBC, Institutional Biosafety Committee, Regulatory Compliance, research, Risk Management

Biotech sponsors, IRB (Institutional Review Board), IBC (Institutional Biosafety Committee), DMCs (Data Monitoring Committees), EACs (Ethics Advisory Committees), Regulatory compliance, Clinical trials, Gene therapy research, Risk management

Cigna Challenges FTC’s Report on Pharmacy Benefit Managers, Alleging Unconstitutional Actions and Misleading Claims

7 months ago talkbio0Tagged Benefit Managers, Cigna, Claims, Express, Health Care Systems, misleading, PBMs, Pharmaceutical Services, Prices, Unconstitutional Report, United States Federal Trade Commission

Cigna, FTC, Pharmacy Benefit Managers (PBMs), Express Scripts, Unconstitutional Report, Misleading Claims, Drug Prices, Healthcare System

FDA Updates Guidance to Combat Online Misinformation About Medical Products

7 months ago talkbio0Tagged Advice, Clarity, medical products, online misinformation, public health medicine (field), regulatory, United States Food and Drug Administration

FDA, online misinformation, medical products, guidance, regulatory clarity, public health

Abbott Launches Lingo, First Over-the-Counter Continuous Glucose Monitor for Health and Wellness in the US

8 months ago talkbio0Tagged abbott, continuous glucose, Continuous Glucose Monitoring System, Health, Lingo, Preventive monitoring

Abbott, Lingo, Over-the-Counter CGM, Health and Wellness, Continuous Glucose Monitoring

The Post-Chevron Regulatory Landscape: Implications for the FDA and Healthcare Industry

8 months ago talkbio0Tagged Administrative procedure, Boards (medical device), Chevron Deference, Corner Post, court, Federal Reserve System, Governors, Healthcare Industry, judicial, Landscapes, Legal, Loper Bright Enterprises, Raimondo, regulatory, Supreme, United States Food and Drug Administration

Chevron deference, FDA, regulatory landscape, healthcare industry, Supreme Court ruling, Loper Bright Enterprises v. Raimondo, Corner Post, Inc. v. Board of Governors of the Federal Reserve System, Administrative Procedure Act (APA), judicial scrutiny, legal challenges, regulatory implications.